These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28961156)

  • 1. Exome array analysis identifies GPR35 as a novel susceptibility gene for anthracycline-induced cardiotoxicity in childhood cancer.
    Ruiz-Pinto S; Pita G; Patiño-García A; Alonso J; Pérez-Martínez A; Cartón AJ; Gutiérrez-Larraya F; Alonso MR; Barnes DR; Dennis J; Michailidou K; Gómez-Santos C; Thompson DJ; Easton DF; Benítez J; González-Neira A
    Pharmacogenet Genomics; 2017 Dec; 27(12):445-453. PubMed ID: 28961156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients.
    Ruiz-Pinto S; Pita G; Martín M; Alonso-Gordoa T; Barnes DR; Alonso MR; Herraez B; García-Miguel P; Alonso J; Pérez-Martínez A; Cartón AJ; Gutiérrez-Larraya F; García-Sáenz JA; Benítez J; Easton DF; Patiño-García A; González-Neira A
    Breast Cancer Res Treat; 2018 Jan; 167(1):249-256. PubMed ID: 28913729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification and pattern of cardiotoxicity in pediatric Ewing sarcoma.
    Moussa E; Zamzam M; Kamel A; Salah Z; Attia I; Gaber L; Soliman R; Ezzat S
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):53-56. PubMed ID: 28258912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.
    Sági JC; Egyed B; Kelemen A; Kutszegi N; Hegyi M; Gézsi A; Herlitschke MA; Rzepiel A; Fodor LE; Ottóffy G; Kovács GT; Erdélyi DJ; Szalai C; Semsei ÁF
    BMC Cancer; 2018 Jul; 18(1):704. PubMed ID: 29970035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic factors in anthracycline-induced cardiotoxicity in patients treated for pediatric cancer.
    Petrykey K; Andelfinger GU; Laverdière C; Sinnett D; Krajinovic M
    Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):865-883. PubMed ID: 32772754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal study.
    Brown TR; Vijarnsorn C; Potts J; Milner R; Sandor GG; Fryer C
    Pediatr Blood Cancer; 2013 May; 60(5):842-8. PubMed ID: 23382019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.
    Aminkeng F; Bhavsar AP; Visscher H; Rassekh SR; Li Y; Lee JW; Brunham LR; Caron HN; van Dalen EC; Kremer LC; van der Pal HJ; Amstutz U; Rieder MJ; Bernstein D; Carleton BC; Hayden MR; Ross CJ;
    Nat Genet; 2015 Sep; 47(9):1079-84. PubMed ID: 26237429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity.
    Ding Y; Du K; Niu YJ; Wang Y; Xu X
    Oxid Med Cell Longev; 2022; 2022():5818612. PubMed ID: 35965684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of hiPSC to explicate genomic predisposition to anthracycline-induced cardiotoxicity.
    Magdy T; Burridge PW
    Pharmacogenomics; 2021 Jan; 22(1):41-54. PubMed ID: 33448871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting and Preventing Anthracycline-Related Cardiotoxicity.
    Armenian S; Bhatia S
    Am Soc Clin Oncol Educ Book; 2018 May; 38():3-12. PubMed ID: 30231396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.
    Hudson MM; Rai SN; Nunez C; Merchant TE; Marina NM; Zalamea N; Cox C; Phipps S; Pompeu R; Rosenthal D
    J Clin Oncol; 2007 Aug; 25(24):3635-43. PubMed ID: 17704413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cardiac effects of treatment for childhood leukemia.
    Urbanova D; Urban L; Simkova I; Danova K; Mikuskova E; Mladosievicova B
    Neoplasma; 2010; 57(2):179-83. PubMed ID: 20099983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors.
    Hildebrandt MAT; Reyes M; Wu X; Pu X; Thompson KA; Ma J; Landstrom AP; Morrison AC; Ater JL
    Sci Rep; 2017 Aug; 7(1):9698. PubMed ID: 28851949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracycline induced cardiotoxicity in adult cancer patients: a prospective cohort study from a specialized oncology treatment centre in Uganda.
    Kibudde S; Mondo CK; Kibirige D; Walusansa V; Orem J
    Afr Health Sci; 2019 Mar; 19(1):1647-1656. PubMed ID: 31148994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline-induced cardiotoxicity in patients with paediatric bone sarcoma and soft tissue sarcoma.
    Bini I; Asaftei SD; Riggi C; Tirtei E; Manicone R; Biasin E; Basso ME; Agnoletti G; Fagioli F
    Cardiol Young; 2017 Nov; 27(9):1815-1822. PubMed ID: 28780919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
    Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
    BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthracycline-induced cardiotoxicity in diffuse large B-cell lymphoma: NT-proBNP and cardiovascular score for risk stratification.
    Ferraro MP; Gimeno-Vazquez E; Subirana I; Gómez M; Díaz J; Sánchez-González B; García-Pallarols F; Martínez L; Ble M; Molina L; Belarte LC; Abella E; Elosua R; Comín-Colet J; Salar A
    Eur J Haematol; 2019 Jun; 102(6):509-515. PubMed ID: 30972815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer.
    Dietz AC; Sivanandam S; Konety S; Kaufman CL; Gage RM; Kelly AS; Neglia JP; Mulrooney DA
    J Cancer Surviv; 2014 Jun; 8(2):183-9. PubMed ID: 24317971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.